Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression (Q38907228)

7 September 2017

Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression (English)

1 reference

7 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Q Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Y Yin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

J He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Q Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

X Qian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Y You

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Z Lu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

S C Peiper

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Y Shu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

B-H Jiang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

23 February 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

5482-5493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25703326%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2015.6

3 June 2020

exact match

0 references

cites work

New roles for pyruvate kinase M2: working out the Warburg effect

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

PKM2 and the tricky balance of growth and energy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Pyruvate kinase M2 is a phosphotyrosine-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.6

Suppression of growth and transformation and induction of apoptosis by EGR-1.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25703326

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/25703326